Pre-formulated therapeutic oils and active bioactive precursors engineered under stringent ISO 9001 and GMP manufacturing lines for immediate pharmaceutical and personal care deployment.
Unraveling the molecular pathways of Syzygium aromaticum (Eugenia caryophyllata) essential oil in gingival cellular health, anaerobic pathogen suppression, and sustained pulpal desensitization.
Eugenol (4-allyl-2-methoxyphenol) serves as an agonist to transient receptor potential vanilloid-1 (TRPV1) ion channels in peripheral gingival nerve endings. Initial receptor stimulation triggers rapid refractory desensitization, blocking nociceptive signal transmission along A-delta and C nerve fibers to eliminate acute localized dentinal and gingival pain.
Clove oil exerts broad-spectrum bactericidal efficacy against strict oral anaerobes, notably Porphyromonas gingivalis, Treponema denticola, and Fusobacterium nucleatum. The lipophilic phenylpropanoid framework destabilizes bacterial phospholipid bilayer integrity, promoting cellular extravasation and blocking quorum sensing within subgingival plaque.
In flamed gingival tissues, eugenol downregulates cyclooxygenase-2 (COX-2) gene expression and inhibits nitric oxide synthase (iNOS). This cascade suppresses downstream prostaglandins (PGE2) and tumor necrosis factor-alpha (TNF-α), attenuating vascular extravasation, erythema, and bleeding on probing in clinical gingivitis models.
Translating natural clove botanical actives into stable, bio-available oral care SKUs across pharmaceuticals, professional endodontics, and over-the-counter consumer gingival therapies.
Engineered using chitosan or hydroxypropyl methylcellulose (HPMC) polymers loaded with 1.5% to 3.0% rectified clove oil. Delivers localized, sustained gingival pocket drug release over 6 hours for postoperative periodontal surgery recuperation.
Alcohol-free, optically transparent oral rinses utilizing self-emulsifying surfactant systems (Polysorbate-20 / PEG-40). Encapsulates hydrophobic eugenol droplets below 50nm to ensure interdental penetration without oral mucosal irritation.
Clinical-grade pharmaceutical formulations fulfilling ISO 3107. Serves as intermediate temporary restorative materials, root canal sealers, and periodontal surgical dressings requiring strictly verified low acidic impuritites and controlled chelation kinetics.
Silica-base abrasive dentifrices combined with micronized clove bud essential oil and potassium nitrate. Eliminates hypersensitivity while delivering prolonged fresh breath and gingival margin micro-circulation stimulation.
Addressing the inherent thermodynamic volatility, organoleptic intensity, and oxidation kinetics of natural clove oil via advanced pharmaceutical nanotechnologies.
Complexation of eugenol with beta-cyclodextrin host molecules shields reactive allyl and phenolic hydroxyl groups. This nanotechnology reduces sensory pungency while elevating thermodynamic stability at elevated compounding temperatures (up to 140°C) for chewing gums, dissolvable oral strips, and high-shear pastes.
Sub-micron lipid matrices entrap pure clove oil within physiological lipid cores, establishing targeted adherence to inflamed gingival sulcus walls. In vitro release curves demonstrate continuous therapeutic eugenol dissolution exceeding 18 hours, suppressing subgingival recolonization after scaling and root planing.
Developing pH-responsive and esterase-triggered microcapsules that release active eugenol specifically in the presence of acidic bacterial microenvironments (pH < 5.5) generated by anaerobic oral pathogens, minimizing active chemical wastage and optimizing host tissue biocompatibility.
Inside Jiangxi Baicao Pharmaceutical: 28,600 m² of automated GMP production, precision fractional distillation, and multi-stage analytical verification driving global supply stability.
Employing computer-regulated SS316L multistage distillation columns operated under strict negative pressures (-0.098 MPa). This process protects heat-sensitive botanical molecules while selectively concentrating eugenol from 78% crude feedstock up to a verified 95%+ high-grade pharmaceutical active fraction.
Each production lot passes automated in-house GC-FID, GC-MS (Agilent 7890B/5977A), and HPLC chromatography. Rigorous validation guarantees exact fingerprint verification, quantifying beta-caryophyllene, humulene, and eugenyl acetate while eliminating pesticide, solvent, and phthalate residues.
Two distinct workshops spanning 12 continuous processing lines strictly isolate essential oil extraction from botanical extract powders. High-efficiency HEPA particulate air filtration, CIP (Clean-In-Place) sanitation cycles, and ISO Class 8 cleanrooms eliminate cross-contamination risks across OEM batches.
A rigorous analytical comparison enabling B2B supply chain managers, QA directors, and corporate procurement teams to benchmark industrial clove oil grades against international pharmacopeial mandates.
| Evaluation Parameter | Commercial Flavour Grade | USP / EP Pharmacopeial Grade | Baicao Pharma Factory 4.0 Standard |
|---|---|---|---|
| Eugenol Assay (GC-FID) | 70.0% – 80.0% | 80.0% – 90.0% | 85.0% – 93.0% (Customizable) |
| Heavy Metals (Pb, Cd, As, Hg) | < 20.0 ppm | < 10.0 ppm | < 2.0 ppm (ICP-MS Verified) |
| Optical Rotation (20°C) | -1.5° to 0.0° | -1.5° to 0.0° | -1.2° to -0.2° Controlled |
| Refractive Index (20°C) | 1.528 – 1.537 | 1.528 – 1.537 | 1.530 – 1.535 Precise Window |
| Pesticide Residue Limits | Standard Screening | EP 2.8.13 Compliant | ND (Zero Detectable Limit) |
| Batch Retained Archives | Optional / Variable | 24 Months | 36 Months Full Physical Lot Archive |
Facilitating seamless international market entry across North America, the European Union, the Middle East, and Asia-Pacific through comprehensive technical dossier authoring.
Every commercial consignment arrives backed by comprehensive Certificates of Analysis (COA), safety data sheets according to GHS/CLP standards, 26-Allergen Statements, IFRA 51st Amendment certificates, and declared Non-GMO and BSE/TSE statements required for tier-1 regulatory submissions.
Formulations align precisely with US FDA Generally Recognized as Safe (GRAS) guidelines and European Cosmetic Products Notification Portal (CPNP) standards. Custom blending guarantees that finished mouthwashes and gels remain within restricted maximum allowable eugenol oral thresholds.
Industrial packaging spans food-grade fluorinated HDPE drums (25kg), epoxy-phenolic-lined steel drums (180kg/200kg), and automated private-label amber glass bottling (10ml – 100ml) packed with nitrogen flushing to forestall oxidative degradation in transit.
Complementary botanical isolates, carrier media, and standardized aromatic fractions engineered for integrated periodontal, dental care, and dermatological product pipelines.
Essential answers for formulation scientists, quality assurance managers, and global procurement officers sourcing ODM clove oil for gum health.
Clove Bud Oil (Flos Caryophylli) contains 80% to 90% eugenol accompanied by a high fraction (4% to 15%) of eugenyl acetate and caryophyllene, which imparts a smooth, rounded flavor and superior mucosal tolerability. Conversely, Clove Leaf Oil typically carries 75% to 85% eugenol with virtually no eugenyl acetate and elevated sesquiterpene hydrocarbon levels, creating a harsh, pungent sensory profile prone to soft-tissue stinging. For pharmaceutical periodontal gels and sublingual applications, Clove Bud Oil is universally mandated.
Adulteration using petroleum-derived synthetic eugenol or guaiacol derivatives is detected via Carbon-14 (¹&sup4;C) radiocarbon isotopic testing and high-resolution Gas Chromatography-Combustion-Isotope Ratio Mass Spectrometry (GC-C-IRMS). In addition, our automated GC-MS library validates the natural chiral matrix and natural co-constituents (α-humulene, β-caryophyllene, and chavicol), verifying that the profile corresponds 100% to natural Syzygium aromaticum botanical synthesis.
Eugenol possesses limited water solubility (~2.46 mg/mL at 25°C) and is vulnerable to discoloration and oxidative polymerization upon light and alkaline exposure. To ensure a 36-month shelf life in oral rinses and gels, formulators must buffer formulations to pH 5.2 – 6.8, utilize non-ionic micro-emulsifiers (e.g., polyoxyethylene sorbitan monooleate), and incorporate secondary lipophilic antioxidants such as natural Mixed Tocopherols or Rosemary Extract with high Rosmarinic Acid content.
For bulk active pharmaceutical ingredients (API) and cosmetic grade clove oil, our standard industrial MOQ starts at 25 kg in UN-certified fluorinated drums, scaling to full 200 kg steel drums and multi-ton containerized isotanks. For turnkey private-label products (custom gingival relief dropper bottles, oral sprays, or pre-filled syringes), our minimum batch run typically begins at 3,000 units with complete custom box packaging, tamper-evident seals, and localized regulatory labeling.
Yes. Jiangxi Baicao Pharmaceutical operates an open-audit policy for validated corporate partners. We regularly host scheduled GMP site audits from third-party registrars (SGS, Intertek, TÜV) as well as direct corporate QA delegations. Remote live-video audit verification, comprehensive documentation archives (Batch Production Records, Validation Protocols, Cleaning Validation Reports), and blind retention split samples are accessible upon mutual NDA ratification.
Request physical reference standards, comprehensive GC-MS / HPLC chromatograms, technical formulation dossiers, and direct factory-gate volume pricing from our technical application specialists.